Atsena Therapeutics rakes in $55m Series A
Atsena Therapeutics, a clinical-stage gene therapy company, has secured $55 million in Series A financing.
Atsena Therapeutics, a clinical-stage gene therapy company, has secured $55 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination